Similarly, an international prospective study in the United States, Italy, and Spain found that ovarian cancer patients were highly satisfied with oncology clinic-based genetic testing for BRCA1 and BRCA2 [13]. This evidence concerns the gene BRCA2 and ovarian cancer.